Read the latest press releases from Calliditas Therapeutics by clicking on a title below.

For press enquiries please contact us.

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q2 report

Calliditas Therapeutics to Present at Redeye Growth Day

Calliditas Therapeutics to host conference call to provide Business Update and 2019 Q1 report

Elmar Schnee and Diane Parks proposed as new board members of Calliditas Therapeutics

Calliditas Therapeutics to Present at the Needham Healthcare Conference

Calliditas Therapeutics to Present at March Investor Conferences

Calliditas Therapeutics to host conference call to provide Business Update and 2018 full-year report

Calliditas Therapeutics appoints Frank Bringstrup as VP Regulatory Affairs

Calliditas Therapeutics appoints Andrew Udell to VP Commercial, North America

Calliditas Therapeutics AB
Kungsbron 1, C8
SE-111 22 Stockholm
Sweden

Company number: 556659-9766

© Calliditas Therapeutics AB 2019